VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

UKONS 2020 | COVID-19: launching a self-administration service

Fleur Harvey • 19 Nov 2020
UKONS 2020
General Antibodies Bortezomib Cytarabine Trastuzumab
Nursing Pharmacy

Fleur Harvey, The Royal Marsden NHS Foundation Trust, London, UK, discusses the launch of a self-administration service during COVID-19 with four agents (cytarabine, bortezomib, trastuzumab, denosumab) at the Royal Marsden NHS Foundation Trust. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Fleur Harvey

1:13
COVID-19-mediated streamlining of processes in the UK
Fleur Harvey • 19 Nov 2020

Related Videos

3:58
BrainStorm: improving prediction, diagnosis and management of brain metastases
Ahmad Awada • 6 May 2021
6:04
Cellular therapy in solid tumors
Andrew Furness • 27 Apr 2021
9:36
The role of virtual consultations in cancer treatment
Robert Rintoul • 26 Apr 2021
2:19
Inequalities in biomarker testing
Alastair Greystoke • 23 Apr 2021
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals